Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. (MDGL) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
MDGL · net income · updated Jun 8, 2026
Core profitability metrics
MDGL · net income · margin · TTM · CAGRNet income was −$288.3M for FY2025 (fiscal year ending 2025-12-31), up 38.1% year-over-year. Net profit margin was -30.1%.
Annual net income history
▸ FMP /income-statement · Annual · MDGL net income history · MDGL profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Madrigal Pharmaceuticals, Inc. (MDGL) reported net income of −$288.3M for FY2025 (fiscal year ending 2025-12-31), up 38.1% year-over-year. The net profit margin was -30.1% — meaning the company kept $-0.30 of every dollar of revenue as profit.
Madrigal Pharmaceuticals, Inc. has not yet achieved annual profitability based on available data (15 fiscal years). The company has reported net losses across all available periods.
Madrigal Pharmaceuticals, Inc.'s net profit margin was -30.1% for FY2025, based on the latest annual results.
Investors sometimes search for "Madrigal Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from MDGL net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
MDGL net income · 4 questionsMadrigal Pharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $288.3M for FY2025.
▸ Source: FMP /income-statement · GAAP · Madrigal Pharmaceuticals, Inc. · Madrigal Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026